Can B Corp (CANB)

[CHnJUP]

Not everyone has had 2 RS....bummer for your timing.
Me I'm sitting pretty waiting for the Nasdaq in April..then booooom. Good luck though penny. Hang in there.

[waterchaser]

Clearly, the CANB pump has ended.
This one is dead money.
On to the next scam I suppose.

[Penny Masters]

You realize the real price after both RS is now actually .0014 and CANB is all but worthless.

This bleeds out from here and nothing to hold it up.

[CHnJUP]

nasdaq on the horizon will help. Be patient and be positive (penny). Here's to a great 2022. CANBD LFGOOOOOOOO

[Penny Masters]

Maybe another RS to get CANB moving. LOL Some need 100.00 to get back to even with this pig with lipstick.

This one is over and done. It will bleed out like the past RS.

[CHnJUP]

How come you guys all post the same news? Yeah that's great we got a deal but let's get this stock moving man. Big $$$$$ Nasdaq soon.

[skyhawk66]

Yep, Great News Continues for CANB Indeed. No wonder Loading and Holding Continues.

Can B Corp. Executes Joint Venture with PrimeX Making its CBD Products Available in Brazil

Thu, March 3, 2022, 6:00 AM
In this article:

CANBD
+13.73%

Enabling Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million Consumers

HICKSVILLE, NY / ACCESSWIRE / March 3, 2022 / Can B Corp. (OTCQB:CANBD) ("Can B'' or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its formation of a joint venture with PrimeX, a marketing, sales, and distribution company, for its CBD products in Brazil.

PrimeX has a contract with Biocase Brasil to produce CBD products for the Brazilian market.
Biocase is a company focused on: local distribution, an intensive education program for doctors (MDs), production of oils, capsules, and creams through local facilities, and the development of a biotech laboratory for cannabis testing and extraction.

Biocase Brasil has a strong network of doctors in Brazil and provides education, research, products development, and tests for the Brazilian market. Brazil relies on medical clinical trials to test CBD products for new categories, such as beauty, veterinary use, and food, before regulation permits the distribution to pharmacies and online sales. BiocaseBrasil patients' also have access to prescriptions and Anvisa licenses!

PrimeX services 120,000 retailers in Brazil, which includes markets, pharmacies, and bodegas, a country that recently approved the sale of CBD products in pharmacies. The joint venture will utilize PrimeX's existing distribution relationships in Brazil.

The largest country in South America, Brazil is the fourth biggest pharmaceutical market in the world. The Brazilian National Health System is one of the largest public health systems in the world. In 2019, Brazil had 114,352 community pharmacies (76.8% privately owned), which represent the first point of access to healthcare in Brazil due to their wide distribution.

Medical cannabis and CBD are expected to surge in Brazil with the passage of new legislation, with estimates that the sector could reach $4.7 billion in sales in the next three years. Up until recently, CBD in Brazil was permitted only for medical use with authorization from the National Sanitary Surveillance Agency. Regulations are in place for medical cannabis and hemp opening up a market of 210 million consumers.

There are only a few companies in Brazil - CBD Vida being one- selling CBD-based pharmaceuticals through prescription and medical reports, Only a handful of importers have established distribution in Brazil, including GW Pharmaceuticals, Biocase Brazil, which sells its Sativex CBD-based medicine in pharmacies, and Biocase sells Allandiol Full and Broad.

Mario Lacourt, PrimeX's Chief Executive Officer, stated, "We are very excited to roll out Can B's CBD products in Brazil. After careful consideration, Biocase Brasil chose Can B for its high standards of manufacturing and processing and quality products. The CBD category in Brazil is ever-expanding to new categories and we are very well-positioned to distribute Can B's products to the majority of pharmacies, markets, and bodegas in Brazil."

Marco Alfonsi, Can B's Chief Executive Officer, stated, "This is a significant expansion milestone for our company as Brazil is the fourth biggest pharmaceutical market in the world and we now have access to this huge market via PrimeX. The CBD opportunity in Brazil is emerging with recently passed legislation that is opening up the market to its 210 million people. We look forward to working closely with PrimeX and utilizing its existing relationships with pharmacies in Brazil."

About PrimeX

PrimeX distributes and markets hemp, CBD, D8 smokable, and consumable products in the USA and internationally. PrimeX works with clients to fulfill all their hemp-derived products globally by partnering with companies alike (for example, Dicina 120,000+ points of sale). With access to raw material, pre-roll smokes rolled at 1600/minute to pharmaceutical grade products, PrimeX works to provide top-shelf consumer access.

For additional information, please visit:

https://sateevajoints.com

https://www.biocasebrasil.com

About Can B Corp.

Can B Corp. (OTCQB:CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

For more information about Can B Corp., please visit: CanBCorp.com

Twitter @CanBCorp

Instagram @canbcorp

Facebook @ Can B Corp

YouTube

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape, or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of the latest information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investors and Media:
[e-mail]
[phone]

[badguy3101]

https://www.newmediawire.com/news/can-b-corp-executes-joint-venture-with-primex-making-its-cbd-products-available-in-brazil-6202891





The Badguy

[Penny Masters]

CANB executed the second RS as well. LOL They pretty much executed all share holders and price with it.

True CANB vale is now .0011 after both RS.

[AveragePenny]

$CANB Can B Corp. Executes Joint Venture with PrimeX Making its CBD Products Available in Brazil


https://www.newmediawire.com/news/can-b-corp-executes-joint-venture-with-primex-making-its-cbd-products-available-in-brazil-6202891

Enables Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million Consumers



Hicksville, NY - (NewMediaWire) - March 03, 2022 - Can B Corp. (OTCQB:CANB) ("Can B'' or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its formation of a joint venture with PrimeX, a marketing, sales, and distribution company, for its CBD products in Brazil.



PrimeX has a contract with Biocase Brasil to produce CBD products for the Brazilian market. Biocase is a company focused on: local distribution, an intensive education program for doctors (MDs), production of oils, capsules, and creams through local facilities, and the development of a biotech laboratory for cannabis testing and extraction.

Biocase Brasil has a strong network of doctors in Brazil and provides education, research, products development, and tests for the Brazilian market. Brazil relies on medical clinical trials to test CBD products for new categories, such as beauty, veterinary use, and food, before regulation permits the distribution to pharmacies and online sales. Biocase Brasil patients also have access to prescriptions and Anvisa licenses!

PrimeX services 120,000 retailers in Brazil, which includes markets, pharmacies, and bodegas, a country that recently approved the sale of CBD products in pharmacies. The joint venture will utilize PrimeX's existing distribution relationships in Brazil.

The largest country in South America, Brazil is the fourth biggest pharmaceutical market in the world. The Brazilian National Health System is one of the largest public health systems in the world. In 2019, Brazil had 114,352 community pharmacies (76.8% privately owned), which represent the first point of access to healthcare in Brazil due to their wide distribution.

Medical cannabis and CBD are expected to surge in Brazil with the passage of new legislation, with estimates that the sector could reach $4.7 billion in sales in the next three years. Up until recently, CBD in Brazil was permitted only for medical use with authorization from the National Sanitary Surveillance Agency. Regulations are in place for medical cannabis and hemp opening up a market of 210 million consumers.

There are only a few companies in Brazil - CBD Vida being one - selling CBD-based pharmaceuticals through prescription and medical reports. Only a handful of importers have established distribution in Brazil, including GW Pharmaceuticals, Biocase Brazil, which sells its Sativex CBD-based medicine in pharmacies, and Biocase sells Allandiol Full and Broad.

Mario Lacourt, PrimeX's Chief Executive Officer, stated, "We are very excited to roll out Can B's CBD products in Brazil. After careful consideration, Biocase Brasil chose Can B for its high standards of manufacturing and processing and quality products. The CBD category in Brazil is ever-expanding to new categories and we are very well-positioned to distribute Can B's products to the majority of pharmacies, markets, and bodegas in Brazil."

Marco Alfonsi, Can B's Chief Executive Officer, stated, "This is a significant expansion milestone for our company as Brazil is the fourth biggest pharmaceutical market in the world and we now have access to this huge market via PrimeX. The CBD opportunity in Brazil is emerging with recently passed legislation that is opening up the market to its 210 million people. We look forward to working closely with PrimeX and utilizing its existing relationships with pharmacies in Brazil."

[Penny Masters]

Nasty RS and another RS for CANB. How many are you allowed as they will break that record.

What a mess CANB turned out to be.

[waterchaser]

Interest is growing in the 1:15 REVERSE SPLIT.
Announced February 11th.

(this pump is over, I suppose it’s time to move on)

[Penny Masters]

Looks like 4.00 inbound for the runaway CANB double RS shit show.

[Penny Masters]

A 3rd RS may be needed for NASDAQ. Hahahahahahaha

[Penny Masters]

Look out below as RS killed CANB again. NASTY what these do to share holders and REALLY NASTY CANB did it twice.

Officially a real shit show at CANB

[Penny Masters]

CANB true value now .0018 after two RS. NASTY as this bleeds out share holders again. How this is legal is beyond me.

BUYER BEWARE!

[badguy3101]

Hmm, I've made a TON OF MONEY in the "OTC cesspool." It's awesome!!!!

Feels great!

CANB

NASDAQ




The Badguy

[Penny Masters]

Atta boy and CANB will sell you all you want. This will get cut in half fast as the dumping begins.

[goingupnow0]

Cant wait for Tuesday to buy more!!

[Penny Masters]

Was another CANB RS great news? Good grief they bleed all share holders out again and there was little blood left after the first RS.

[Lowhndcpr]

Notice Marco kept the AS at 1.5 BILLION SHARES while he screwed everyone else

[Lowhndcpr]

$2000 in trades is accumulating?

[Penny Masters]

Nothing to support the CANB pig with lipstick. Use caution as the 2nd RS in a short period will drop daily and nothing anyone can do.

[skyhawk66]

Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.

No wonder All Eyes are focused on CANB 24/7.

*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming

[Penny Masters]

Math does not lie and CANB back to back RS was NASTY!. Glad we both agree, Right!!!

[Penny Masters]

CANB 200-1 and 15-1 RS back to back. Math does not lie and wait till they take this back to .50 again. Too funny and these types are so easy to see for most.

Peace out and hope you do not lose more than you can afford in this disastor.

[goingupnow0]

Right!!!!

[Penny Masters]

CANB true value pre-RS and RS is .0018. Let that sink in, as to how bad CANB really is. No one could get out without 80-95% losses.

[Penny Masters]

Looks like the CANB dump is starting. Looks like 2000 or so shares a day will get dumped into the market. No way out for share holders and sad to see another RS too take what little blood was left of share holders.

[skyhawk66]

Right, lol. CANB going to continue it trajectory North in the weeks and months ahead. As All Eyes follow....we shall see it happen,

[goingupnow0]

Yeah ok, it can and will happen.

[waterchaser]

I don't think FINRA will allow them to reverse split again anytime soon... so that prediction is a bit off.

$20 easily in the coming weeks and months

[skyhawk66]

Wow, More eyes Focused on CANB Now,
Easy to see why:

*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming

[skyhawk66]

Buying more as well. $20 easily in the coming weeks and months.

Nasdaq Bound

[goingupnow0]

I am ty so much!!

[Penny Masters]

Buy more, you deserve it.

Hope you enjoy the massive dump again, as well.

Peace out

[goingupnow0]

Buying more… ty

[Penny Masters]

Maybe a 3rd CANB RS will help. LOL So sad this is allowed as CANB took out all share holders a 2nd time and is basically worthless at this point.

[CHnJUP]

LOL...that's classic LOW. Hope you get to that and dollars above it. GLTA

[Lowhndcpr]

My new cost average is $414 per share. Thanks Marco

[Penny Masters]

Race to sell and NASTY RS here. CANB insiders enrichment at its finest.

[Penny Masters]

RS and RS again killed CANB and they will dump faster than anyone left, dumb enough to hold this pig with lipstick. You do know 95 out of 100 RS OTC plays drop so fast, most cannot get out in time.

True value here is now less than .0019 from the first RS and this RS will make it worthless shortly.

Peace out as CANB bleeds out.

[goingupnow0]

it’s flat for the day. Yeeehaww stocks will keep going up. I’m guessing they’ll come out with good news.

[Penny Masters]

All trying to dump faster and exit CANB before its worth nothing. This is a perfect example of what happens with two RS's in a short period. Amazing it is even legal. Share holders all shafted twice as insiders get rich.

BEWARE of these OTC cesspool plays.

[skyhawk66]

Yep, Loading and Holding.

[goingupnow0]

Very legal, it’s a great stock can’t wait to buy more!!! Thanks love that reverse. Nasdaq next…..$CANBD

[Penny Masters]

CANB be back to 5.00 in a blink. Race to sell off again and no share holders left standing after the 2nd CANB RS.

How is this even legal or allowed? CANB is like the US Gov. and prints money with no regards to anyone involved.

[Penny Masters]

Let the CANB dumping begin. Nasty what they do to share holders and amazing it another RS was allowed.

[Midwestrader]

I've kept a list of 30+ RS's over the last 14 months in my Ihub monitor and at least 95-99% of them destroy shareholders. There are a few that actually go up but it's usually a very small gain. The biggest problem is the trading dries up as it drops and they eventually go zero volume.

Like on this ticker,who the HELL will pay over 8.00 per share when they were paying 50-54 cents per share just one trading day ago? Nothing has changed with the company that makes it worth 8.00 per share,just paperwork shuffled and a few mouse clicks.

What's really off the charts is I've seen the SEC grant reverse splits to CE/skull and crossbone tickers. SERIOUSLY???

And...anyone holding this will be slapped with a fee from your broker for taking shares AWAY from you. Gawd..........

The last RS 1/300 didn’t screw over investors enough when it went from a penny to $3 and quickly sunk down to 50 cent range.

[badguy3101]

Being a millionaire is a great secure feeling. Sure glad CANB will add to that feeling

Vision

Vision

Vision!!!

CANB

NASDAQ




The Badguy